Skip to main content

Table 4 Association between obstetrical history and uptake of three or doses of IPTp with SP

From: Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015–2016

CharacteristicN Total = 1069% women took 3+ dosesRao-Scott F-testp-value
n (%)(95%CI)
Parity
 One child277125 (45.0)37.4–52.9F (3.83, 2158.02) = 2.53820.0407*
 Two children244110 (45.0)36.6–53.7  
 Three children16179 (48.7)40.1–57.3  
 Four children13251 (38.6)29.0–49.3  
 Five or more children25482 (32.4)26.8–38.6  
Timing of 1st ANC visit
 1st trimester222103 (46.2)37.6–54.9F (1.94, 1094.85) = 7.95350.0004*
 2nd trimester753327 (43.5)39.1–48.0  
 3rd trimester9417 (17.8)10.5–28.6  
Number of ANC visits
 4+500260 (52.0)46.2–57.7F (1.85, 1045.90) = 31.8155<0.001*
 3413172 (41.6)35.7–47.7  
 1–215615 (9.9)6.1–15.4  
  1. weighted total frequency, weighted frequency of women who took three or more doses of IPTp-SP, *potential candidate for multivariate logistics regression because p < 0.25